These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38560721)

  • 1. Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study.
    Huang D; Rennie M; Krasovec A; Nagubandi S; Liu S; Ge E; Khehra B; Au M; Sivagnanam S; Kwan V; Rogge C; Mitrev N; Kariyawasam V
    Ther Adv Chronic Dis; 2024; 15():20406223241233203. PubMed ID: 38560721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Lee HS; Park SH; Kim SH; Kim J; Choi J; Lee HJ; Kim WS; Lee JM; Kwak MS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK
    Inflamm Bowel Dis; 2016 Apr; 22(4):912-8. PubMed ID: 26829410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment.
    Maconi G; Lombardini M; Furfaro F; Bezzio C; Zerbi P; Ardizzone S
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1146-51. PubMed ID: 25089547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India.
    Mundhra S; Thomas D; Jain S; Sahu P; Vuyyuru S; Kumar P; Kante B; Panwar R; Sahni P; Chaudhry R; Das P; Makharia G; Kedia S; Ahuja V
    Indian J Gastroenterol; 2023 Jun; 42(3):411-417. PubMed ID: 37171781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
    Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
    J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis.
    Jain S; Namdeo D; Sahu P; Kedia S; Sahni P; Das P; Sharma R; Gupta V; Makharia G; Dar L; Travis SP; Ahuja V
    Intest Res; 2021 Oct; 19(4):438-447. PubMed ID: 33147897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy.
    Powar MP; Martin P; Croft AR; Walsh A; Petersen D; Stevenson AR; Lumley JW; Stitz RW; Radford-Smith GL; Clark DA
    Colorectal Dis; 2013 Mar; 15(3):374-9. PubMed ID: 22849324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.
    Olaisen M; Rydning A; Martinsen TC; Nordrum IS; Mjønes P; Fossmark R
    Scand J Gastroenterol; 2014 Jul; 49(7):845-52. PubMed ID: 24947587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study.
    Kim YS; Kim YH; Kim JS; Jeong SY; Park SJ; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Kim KO; Jang BI; Han DS; Yang SK; Kim WH
    Gut Liver; 2014 Nov; 8(6):643-7. PubMed ID: 25368753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
    Sebastian S; Walker GJ; Kennedy NA; Conley TE; Patel KV; Subramanian S; Kent AJ; Segal JP; Brookes MJ; Bhala N; Gonzalez HA; Hicks LC; Mehta SJ; Lamb CA;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):271-281. PubMed ID: 33545083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
    Battat R; Hemperly A; Truong S; Whitmire N; Boland BS; Dulai PS; Holmer AK; Nguyen NH; Singh S; Vande Casteele N; Sandborn WJ
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):511-518.e6. PubMed ID: 32348905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?
    Melotti L; Rinaldi M; Salice M; Dussias NK; Vanigli N; Calabrese C; Scaioli E; Gabrielli L; Lazzarotto T; Rosini F; Viale P; Gionchetti P; Giannella M; Rizzello F
    Microbiol Spectr; 2024 Nov; 12(11):e0115924. PubMed ID: 39400159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
    Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab
    Vasudevan A; Arachchi A; Scanlon C; Greenhalgh J; Van Langenberg DR
    Ther Adv Chronic Dis; 2019; 10():2040622319825595. PubMed ID: 30728932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults.
    Subhaharan D; Ramaswamy PK; Willmann L; Moattar H; Bhullar M; Ishaq N; Dorrington A; Shukla D; McIvor C; Edwards J; Mohsen W
    World J Gastroenterol; 2023 Apr; 29(16):2469-2478. PubMed ID: 37179589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.
    Festa S; Scribano ML; Pugliese D; Bezzio C; Principi M; Ribaldone DG; Allocca M; Mocci G; Bodini G; Spagnuolo R; Vernia P; Mazzuoli S; Costa F; Barberio B; Cosintino R; Zerboni G; Aratari A; Armuzzi A; Papi C
    United European Gastroenterol J; 2021 May; 9(4):507-516. PubMed ID: 33259773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis.
    Zhang M; Bai X; Zhang H; You Y; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
    Scand J Gastroenterol; 2022 Mar; 57(3):282-289. PubMed ID: 34894997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients admitted with acute, severe ulcerative colitis on biologic therapy: a retrospective analysis from a tertiary referral hospital.
    Sabrie N; Jogendran M; Jogendran R; Targownik LE
    J Can Assoc Gastroenterol; 2024 Aug; 7(4):306-311. PubMed ID: 39139222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort.
    Chaaban L; Cohen B; Cross RK; Kayal M; Long M; Ananthakrishnan A; Melia J
    Inflamm Bowel Dis; 2024 Oct; ():. PubMed ID: 39418122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.